PSO 2023 HRO AND Safety Education Series: Conducting an effective cause analysis
Attendees will gain knowledge on leading practices for triaging events and prioritizing events for improvement, when to conduct RCAs and other types of analyses (common cause, apparent cause, PDSA, etc.), how to disseminate learnings and action plans, and monitor compliance to action plans and improvement.
Target Audience
- Nurses
- Pharmacists
- Physicians
- Other Healthcare Professionals
Learning Objectives
- Discuss the process organizations use to prioritize their events for improvement and determine if further analysis in needed.
- Discuss how organizations select the type of cause analysis to conduct.
- Describe the process for disseminating learnings and action plans across an organization or health system.
- Describe how organizations develop, monitor, and oversee action plans to ensure their effectiveness and sustained improvement.
Additional Information
Attachment | Size |
---|---|
![]() | 134.81 KB |
![]() | 118.9 KB |
Benjamin Wertheimer, MD
Patient Safety Officer, Assistant Professor in Medicine, Hospitalist
NYU Langone Health
Elizabeth Haines, DO, MSc
Service Chief of Quality- Hassenfeld Children’s Hospital
NYU Langone Health
Mbonu Ikezuagu, MD, FACP, CPE
Vice President & Chief Quality Officer
ThedaCare
Tami Flemmer, MSN, RN, CPHRM
Senior Director Risk Management
Bismarck
Sanford Health
A. Joy Rivera, PhD
Human Factors Engineer,
Executive Director, Patient Safety & Patient Relations
Froedtert Health
Markan-Aurora, Sumita, MD
System Director, Patient Safety and Clinical Outcomes
SSM Health
Craig Clapper, PE
Executive advisor
SSM Health
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
- No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA off-label/unapproved usage
Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Joint Accreditation Statement
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement(s)
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 CBRN
- 1.00 General CE - Attendance